메뉴 건너뛰기
The Lancet
Volumn 372, Issue 9633, 2008, Pages 92-93
Vitespen: a vaccine for renal cancer?
Author keywords

[No Author keywords available]
Indexed keywords

CANCER VACCINE; VITESPEN;
EID: 46749131796     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60698-4     Document Type: Note
Times cited : (12)
References (7)
  • 1
    • 46749085802 scopus 로고    scopus 로고
    • An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial
    • for the C-100-12 RCC Study Group 10.1016/S0140-6736(08)60697-2 published online July 4.
    • Wood C., Srivastava P., Bukowski R., et al., for the C-100-12 RCC Study Group. An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial. Lancet (2008) 10.1016/S0140-6736(08)60697-2 published online July 4.
    • (2008) Lancet
    • Wood, C.1    Srivastava, P.2    Bukowski, R.3
  • 2
    • 0035925608 scopus 로고    scopus 로고
    • Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents
    • Srivastava P., and Amato R. Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents. Vaccine 19 (2001) 2590-2597
    • (2001) Vaccine , vol.19 , pp. 2590-2597
    • Srivastava, P.1    Amato, R.2
  • 3
    • 42149092508 scopus 로고    scopus 로고
    • Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings
    • Jonasch E., Wood C., Tamboli P., et al. Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings. Br J Cancer 98 (2008) 1336-1341
    • (2008) Br J Cancer , vol.98 , pp. 1336-1341
    • Jonasch, E.1    Wood, C.2    Tamboli, P.3
  • 4
    • 10744233222 scopus 로고    scopus 로고
    • Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer
    • Mazzaferro V., Coppa J., Carrabba M., et al. Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer. Clin Cancer Res 9 (2003) 3235-3245
    • (2003) Clin Cancer Res , vol.9 , pp. 3235-3245
    • Mazzaferro, V.1    Coppa, J.2    Carrabba, M.3
  • 5
    • 27144500671 scopus 로고    scopus 로고
    • Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma
    • Rosenberg S., Sherry R., Morton K., et al. Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. J Immunol 175 (2005) 6169-6176
    • (2005) J Immunol , vol.175 , pp. 6169-6176
    • Rosenberg, S.1    Sherry, R.2    Morton, K.3
  • 6
    • 20244366111 scopus 로고    scopus 로고
    • Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
    • Dudley M., Wunderlich J., Yang J., et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23 (2005) 2346-2357
    • (2005) J Clin Oncol , vol.23 , pp. 2346-2357
    • Dudley, M.1    Wunderlich, J.2    Yang, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.